172 related articles for article (PubMed ID: 6221436)
1. The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects.
Buchanan MR; Rischke JA; Butt R; Turpie AG; Hirsh J; Rosenfeld J
Thromb Res; 1983 Jan; 29(2):125-39. PubMed ID: 6221436
[TBL] [Abstract][Full Text] [Related]
2. Recovery of prostacyclin synthesis by rabbit aortic endothelium and other tissues after inhibition by aspirin.
Frazer CE; Ritter JM
Br J Pharmacol; 1987 May; 91(1):251-6. PubMed ID: 3297227
[TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase.
Buchanan MR; Rischke JA; Hirsh J
Thromb Res; 1982 Mar; 25(5):363-73. PubMed ID: 7071811
[TBL] [Abstract][Full Text] [Related]
4. Sex related differences in platelet function: the effect of aspirin.
Kelton JG; Carter CJ; Santos A; Hirsh J
Blood; 1982 Mar; 59(3):625-7. PubMed ID: 7059670
[TBL] [Abstract][Full Text] [Related]
5. Effect of aspirin and salicylate on platelet-vessel wall interactions in rabbits.
Buchanan MR; Hirsh J
Arteriosclerosis; 1984; 4(4):403-6. PubMed ID: 6380468
[TBL] [Abstract][Full Text] [Related]
6. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
Socini A; Petroni A; Colli S; Colombo C; Galli C
Pharmacol Res Commun; 1982 Mar; 14(3):189-97. PubMed ID: 7048340
[No Abstract] [Full Text] [Related]
7. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
Preston FE; Greaves M; Jackson CA; Stoddard CJ
Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
[TBL] [Abstract][Full Text] [Related]
8. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency.
Fuse I; Ootsuka T; Hattori A; Mito M; Shibata A
Int J Hematol; 1996 Jun; 63(4):317-24. PubMed ID: 8762815
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
Kyrle PA; Eichler HG; Jäger U; Lechner K
Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
[TBL] [Abstract][Full Text] [Related]
10. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
[TBL] [Abstract][Full Text] [Related]
11. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin.
McDonald JW; de Kergommeaux BD; Ali M; Hayward CP
Prostaglandins Leukot Med; 1983 Nov; 12(3):235-44. PubMed ID: 6419233
[TBL] [Abstract][Full Text] [Related]
14. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.
Weksler BB; Tack-Goldman K; Subramanian VA; Gay WA
Circulation; 1985 Feb; 71(2):332-40. PubMed ID: 3880671
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
[TBL] [Abstract][Full Text] [Related]
16. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of copper-aspirin complex on platelet aggregation.
Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
[TBL] [Abstract][Full Text] [Related]
18. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
Schafer AI; Crawford DD; Gimbrone MA
J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
[TBL] [Abstract][Full Text] [Related]
19. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man.
Cerletti C; Gambino MC; Bucchi F; Rajtar G; Riva E; de Goetano G
Agents Actions Suppl; 1986; 20():239-48. PubMed ID: 3101444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
